We saw the amazing performance of the two mRNA COVID vaccines from Pfizerand Moderna in their RCTs. As encouraging as trial performance is, we always want to see how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now havethree new pieces of information on that. And, for the cherry on top, we get evidence ofperformance against asymptomatic infection! Dr. Jarvis does a quick review of the latestevidence on vaccine performance.